FDA Shift On BPA May Tighten Squeeze On Infant Formula Manufacturers

FDA's shift in position regarding the safety of bisphenol A likely will expedite the trend toward BPA-free packaging among infant formula marketers, even though existing science does not demonstrate a proven threat to babies and children

More from Archive

More from Pink Sheet